GlassScriptPhysician profile
Justin W Smith
NPI 1245556307
$10,243.65
in general payments reported to CMS, 2019-2025
33 companies · $1,859 in 2025
The $1,859 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,357 · 2020: $211 · 2021: $628 · 2022: $1,216 · 2023: $1,552 · 2024: $1,421 · 2025: $1,859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,368 · Travel and Lodging: $1,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,368.46 |
| Travel and Lodging | $1,463.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,224.20 | 2019 | |
| Medtronic, INC. | $1,880.65 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $1,204.45 | 2019-2025 | Watchman Flx, Watchman, Watchman Access System |
| Biosense Webster, INC. | $1,029.04 | 2019-2025 | Carto 3, Qdot Micro Catheter |
| Abbott Laboratories | $641.98 | 2019-2023 | Assurity |
| E.R. Squibb & Sons, L.L.C. | $504.44 | 2019-2025 | Eliquis, Camzyos |
| Atricure, INC. | $288.31 | 2020-2024 | |
| Medical Device Business Services, INC. | $233.31 | 2019-2023 | Carto 3 |
| Janssen Pharmaceuticals, INC | $231.35 | 2019-2024 | Xarelto |
| Amgen INC. | $187.24 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $174.17 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.05 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $169.01 | 2022-2024 | Verquvo |
| Pfizer INC. | $162.31 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $160.22 | 2022-2024 | Farxiga, Brilinta |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $152.65 | 2019-2024 | |
| Philips North America LLC | $115.60 | 2019-2025 | (Ck4) Mcot, Mcot, (Dd1) Duo Hybrid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.90 | 2022-2024 | Jardiance |
| Baxter Healthcare | $86.05 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Cardiva Medical, INC. | $82.60 | 2021-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Abiomed | $74.03 | 2020-2024 | Impella |
| Bardy Diagnostics, INC. | $65.00 | 2020-2021 | |
| Esperion Therapeutics, INC. | $60.58 | 2024-2025 | Nexletol |
| Kestra Medical Technology Services, INC. | $50.78 | 2024-2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $42.99 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $29.75 | 2022 | |
| Preventice Services, LLC | $23.88 | 2021 | |
| Impulse Dynamics (USA) INC. | $22.95 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $18.46 | 2024 | Arcalyst |
| Terumo Medical Corporation | $18.39 | 2020 | |
| Novo Nordisk INC | $17.45 | 2023 | Wegovy |
| Lexicon Pharmaceuticals, INC. | $16.71 | 2023 | Inpefa |
| Braemar Manufacturing, LLC | $14.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.